Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sol Ji | - |
dc.contributor.author | Cho, Bumrae | - |
dc.contributor.author | Koo, Ok Jae | - |
dc.contributor.author | Kim, Hwajung | - |
dc.contributor.author | Kang, Jung Taek | - |
dc.contributor.author | Hurh, Sunghoon | - |
dc.contributor.author | Kim, Su Jin | - |
dc.contributor.author | Yeom, Hye Jung | - |
dc.contributor.author | Moon, Joonho | - |
dc.contributor.author | Lee, Eun Mi | - |
dc.contributor.author | Choi, Ji Yei | - |
dc.contributor.author | Hong, Ju Ho | - |
dc.contributor.author | Jang, Goo | - |
dc.contributor.author | Hwang, Joing-Ik | - |
dc.contributor.author | Yang, Jaeseok | - |
dc.contributor.author | Lee, Byeong Chun | - |
dc.contributor.author | Ahn, Curie | - |
dc.date.accessioned | 2021-09-05T08:35:44Z | - |
dc.date.available | 2021-09-05T08:35:44Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-06 | - |
dc.identifier.issn | 0962-8819 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/98454 | - |
dc.description.abstract | Generation of transgenic pigs for xenotransplantation is one of the most promising technologies for resolving organ shortages. Human heme oxygenase-1 (hHO-1/HMOX1) can protect transplanted organs by its strong anti-oxidative, anti-apoptotic, and anti-inflammatory effects. Soluble human TNFRI-Fc (shTNFRI-Fc) can inhibit the binding of human TNF-alpha (hTNF-alpha) to TNF receptors on porcine cells, and thereby, prevent hTNF-alpha-mediated inflammation and apoptosis. Herein, we successfully generated shTNFRI-Fc-F2A-HA-hHO-1 transgenic (TG) pigs expressing both shTNFRI-Fc and hemagglutinin-tagged-human heme oxygenase-1 (HA-hHO-1) by using an F2A self-cleaving peptide. shTNFRI-Fc and HA-hHO-1 transgenes containing the F2A peptide were constructed under the control of the CAG promoter. Transgene insertion and copy number in the genome of transgenic pigs was confirmed by polymerase chain reaction (PCR) and Southern blot analysis. Expressions of shTNFRI-Fc and HA-hHO-1 in TG pigs were confirmed using PCR, RT-PCR, western blot, ELISA, and immunohistochemistry. shTNFRI-Fc and HA-hHO-1 were expressed in various organs, including the heart, lung, and spleen. ELISA assays detected shTNFRI-Fc in the sera of TG pigs. For functional analysis, fibroblasts isolated from a shTNFRI-Fc-F2A-HA-hHO-1 TG pig (i.e., #14; 1 x 10(5) cells) were cultured with hTNF-alpha (20 ng/mL) and cycloheximide (10 mu g/mL). The viability of shTNFRI-Fc-F2A-HA-hHO-1 TG pig fibroblasts was significantly higher than that of the wild type (wild type vs. shTNFRI-Fc-F2A-HA-hHO-1 TG at 24 h, 31.6 +/- A 3.2 vs. 60.4 +/- A 8.3 %, respectively; p < 0.05). Caspase-3/-7 activity of the shTNFRI-Fc-F2A-HA-hHO-1 TG pig fibroblasts was lower than that of the wild type pig fibroblasts (wild type vs. shTNFRI-Fc-F2A-HA-hHO-1 TG at 12 h, 812,452 +/- A 113,078 RLU vs. 88,240 +/- A 10,438 RLU, respectively; p < 0.05). These results show that shTNFRI-Fc and HA-hHO-1 TG pigs generated by the F2A self-cleaving peptide express both shTNFRI-Fc and HA-hHO-1 molecules, which provides protection against oxidative and inflammatory injury. Utilization of the F2A self-cleaving peptide is a promising tool for generating multiple TG pigs for xenotransplantation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | 2A PEPTIDE | - |
dc.subject | MULTIPLE PROTEINS | - |
dc.subject | HEME OXYGENASE-1 | - |
dc.subject | NUCLEAR TRANSFER | - |
dc.subject | TO-RAT | - |
dc.subject | EXPRESSION | - |
dc.subject | XENOTRANSPLANTATION | - |
dc.subject | REJECTION | - |
dc.subject | KNOCKOUT | - |
dc.subject | BABOONS | - |
dc.title | Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hwang, Joing-Ik | - |
dc.identifier.doi | 10.1007/s11248-013-9780-x | - |
dc.identifier.scopusid | 2-s2.0-84899988010 | - |
dc.identifier.wosid | 000335831600002 | - |
dc.identifier.bibliographicCitation | TRANSGENIC RESEARCH, v.23, no.3, pp.407 - 419 | - |
dc.relation.isPartOf | TRANSGENIC RESEARCH | - |
dc.citation.title | TRANSGENIC RESEARCH | - |
dc.citation.volume | 23 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 407 | - |
dc.citation.endPage | 419 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.subject.keywordPlus | 2A PEPTIDE | - |
dc.subject.keywordPlus | MULTIPLE PROTEINS | - |
dc.subject.keywordPlus | HEME OXYGENASE-1 | - |
dc.subject.keywordPlus | NUCLEAR TRANSFER | - |
dc.subject.keywordPlus | TO-RAT | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | XENOTRANSPLANTATION | - |
dc.subject.keywordPlus | REJECTION | - |
dc.subject.keywordPlus | KNOCKOUT | - |
dc.subject.keywordPlus | BABOONS | - |
dc.subject.keywordAuthor | F2A poly-cistronic vector system | - |
dc.subject.keywordAuthor | shTNFRI-Fc and HO-1 | - |
dc.subject.keywordAuthor | Transgenic pig | - |
dc.subject.keywordAuthor | Xenotransplantation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.